Rising trend of antimicrobial resistance among Neisseria gonorrhoeae isolates and the emergence of N. gonorrhoeae isolate with decreased susceptibility to ceftriaxone

Indian J Med Microbiol. 2015 Jan-Mar;33(1):39-42. doi: 10.4103/0255-0857.148374.

Abstract

Context: Gonorrhoea is one of the most common sexually transmitted infections (STI) in developing countries and is a global health problem.

Aims: To analyze the trend of antimicrobial susceptibility of Neisseria gonorrhoeae isolates over the years, in a tertiary care hospital of North India.

Settings and design: The study population comprised males with urethritis and females with endocervicitis attending STI clinic of our hospital.

Materials and methods: In our STI laboratory, all gonococcal isolates are subjected to antimicrobial susceptibility testing by disc diffusion method as per CLSI guidelines. β-Lactamase production is determined by chromogenic cephalosporin test. Minimum Inhibitory Concentration (MIC) for ceftriaxone is determined by E-test.

Statistical analysis used: Data were expressed as percentages. The differences in percentages were tested for statistical significance by using χ2 test and P values were determined.

Results: The percentage of penicillinase producing N. gonorrhoeae (PPNG) increased from 8% in 1995-96 to 20% in 2004-05 and 88% in 2011-2013. Quinolone-resistant N. gonorrhoeae (QRNG) showed a significant increase from 12% in 1995-96 to 98.3% in 2004-05, while 84% isolates were found to be QRNG by 2011-2013. In January 2013 we detected our first gonococcal isolate with decreased susceptibility to third-generation cephalosporins; Ceftriaxone, Cefixime and Cefpodoxime (MIC for ceftriaxone = 0.19 μg/ml).

Conclusions: The results of our study highlighted an alarming increase in the percentage of PPNG and QRNG strains over the years. Emergence of N. gonorrhoeae isolates with decreased susceptibility to third-generation cephalosporins is a cause of concern and thus emphasises the importance of antimicrobial susceptibility testing.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Ceftriaxone / pharmacology*
  • Drug Resistance, Bacterial*
  • Female
  • Gonorrhea / epidemiology*
  • Gonorrhea / microbiology*
  • Humans
  • India
  • Male
  • Microbial Sensitivity Tests
  • Neisseria gonorrhoeae / drug effects*
  • Neisseria gonorrhoeae / isolation & purification
  • Prevalence
  • Tertiary Care Centers
  • beta-Lactamases / analysis

Substances

  • Anti-Bacterial Agents
  • Ceftriaxone
  • beta-Lactamases